Researchers investigating paper mill effluents and their impact on surface waters in Slovenia have identified endocrine disrupting compounds (EDCs) and their mutagenic and genotoxic properties using gas chromatography–mass spectrometry (GC–MS).
Photo Credit: hxdyl/Shutterstock.com
Researchers investigating paper mill effluents and their impact on surface waters in Slovenia have identified endocrine disrupting compounds (EDCs) and their mutagenic and genotoxic properties using gas chromatography–mass spectrometry (GC–MS) (1).
The pulp and paper industry is the sixth largest industrial polluter in the world releasing a wide range of solid, liquid, and gaseous waste into the environment (2). Most waste is discharged as wastewater, with one ton of paper production creating more than 12 m3 of wastewater. This wastewater represents a significant risk to surface waters often relied upon for drinking water, agricultural activities, industrial use, and in sports and leisure. However, little is known about the types and concentrations of individual toxic compounds released via the paper mill effluents, therefore researchers aimed to quantify the levels of EDCs in effluent from the two major types of paper mill - those which use virgin fibres and those which use recycled fibres. EDCs are significant and known pollutants of paper mill wastewaters, negatively affecting wildlife, and in humans EDCs are suspected to cause cryptorchidism, hypospadias, abnormalities in sperm, and increased hormone-related cancers (3,4). Furthermore, researchers also investigated the mutagenic and cytotoxic activities of the same water samples.
Using GC–MS and bacterial assays researchers confirmed the presence of seven EDCs in both the raw and biologically treated effluents from both paper mills. Significantly higher concentrations in waste from the paper mill that used recycled fibres were found. However, concentrations of EDCs were reduced by 30% following aerobic biological treatment in both mills, and a further 20% reduction was found after anaerobic biological treatment in the recycled fibre paper mill.
Significantly, the study also demonstrated that more than half of raw wastewater samples from the recycled fibre mill were mutagenic and two-thirds were genotoxic. This was not the case in samples taken from virgin fibre mills, and the study therefore concluded that paper mills using virgin fibres do not release mutagenic compounds into the environment during the paper production process, whereas recycled fibre mills do. The researchers were keen to stress that more research was needed to confirm this definitively, but given the results, and the associated risks of mutagenic and genotoxic activity to humans and wildlife, appropriate treatment methods need to be implemented into existing industrial water and wastewater treatment facilities with membrane filtration or advance oxidation processes (AOPs) suggested as potential solutions. - L.B.
References
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.